130 related articles for article (PubMed ID: 12365201)
1. In vitro metabolism of the analgesic agent, tramadol-N-oxide, in mouse, rat, and human.
Wu WN; McKown LA; Codd EE; Raffa RB
Eur J Drug Metab Pharmacokinet; 2002; 27(3):193-7. PubMed ID: 12365201
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites.
Wu WN; McKown LA; Liao S
Xenobiotica; 2002 May; 32(5):411-25. PubMed ID: 12065063
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of two analgesic agents, tramadol-n-oxide and tramadol, in specific pathogen-free and axenic mice.
Wu WN; McKown LA; Codd EE; Raffa RB
Xenobiotica; 2006 Jun; 36(6):551-65. PubMed ID: 16769648
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of the analgesic agent, RWJ-37874, in rat and human.
Wu WN; McKown LA; Carson JR
Eur J Drug Metab Pharmacokinet; 2003; 28(2):101-5. PubMed ID: 12877566
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog.
Wu WN; McKown LA; Gauthier AD; Jones WJ; Raffa RB
Xenobiotica; 2001 Jul; 31(7):423-41. PubMed ID: 11531006
[TBL] [Abstract][Full Text] [Related]
6. In vitro biotransformation of the analgesic agent, RWJ-51784, in rat, dog and human.
Wu WN; McKown LA; Carson JR
Eur J Drug Metab Pharmacokinet; 2003; 28(2):107-11. PubMed ID: 12877567
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.
Shao L; Hewitt M; Jerussi TP; Wu F; Malcolm S; Grover P; Fang K; Koch P; Senanayake C; Bhongle N; Ribe S; Bakale R; Currie M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1674-80. PubMed ID: 18242987
[TBL] [Abstract][Full Text] [Related]
8. Hepatic biotransformation of the new calcium-mimetic agent, RWJ-68025, in the rat and in man--API-MS/MS identification of metabolites.
Wu WN; McKown LA; Rybczynski PJ; Demarest K
J Pharm Pharmacol; 2003 May; 55(5):631-7. PubMed ID: 12831505
[TBL] [Abstract][Full Text] [Related]
9. Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.
Raffa RB; Haslego ML; Maryanoff CA; Villani FJ; Codd EE; Connelly CD; Martinez RP; Schupsky JJ; Buben JA; Wu WN; Takacs AN; Mckown LA
J Pharmacol Exp Ther; 1996 Sep; 278(3):1098-104. PubMed ID: 8819491
[TBL] [Abstract][Full Text] [Related]
10. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
Wu WN; McKown LA; Moyer MD; Reitz AB
J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humans.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2004; 29(4):263-8. PubMed ID: 15726888
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of primary metabolites of tramadol in rat urine by LC-MS(n].
Lu H; Wu D; Yan J; Zeng Q; Wu YP; Sun L
Yao Xue Xue Bao; 2011 Aug; 46(8):968-75. PubMed ID: 22007524
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
Wu WN; McKown LA; Reitz AB
J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
15. Labelling studies for structure elucidation of a new hydroxymetabolite of tramadol.
Potyka U; Paar WD; Sauerbruch T; von Unruh GE
Isotopes Environ Health Stud; 1998; 34(1-2):119-25. PubMed ID: 9854846
[TBL] [Abstract][Full Text] [Related]
16. Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2004; 29(4):257-62. PubMed ID: 15726887
[TBL] [Abstract][Full Text] [Related]
17. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
Wu WN; McKown LA; Kuo GH
Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the alpha-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 fractions -API-MS/MS identification of metabolites.
Wu WN; McKown LA; Kuo GH
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):105-11. PubMed ID: 16010869
[TBL] [Abstract][Full Text] [Related]
19. [Stereoselectivity in O-demethylation of trans tramadol in rat liver microsomes in vitro].
Wang N; Liu HC; Liu CS; Hou YN
Yao Xue Xue Bao; 2002 Mar; 37(3):169-74. PubMed ID: 12579754
[TBL] [Abstract][Full Text] [Related]
20. Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid.
Yu H; Hong S; Jeong CH; Bae JW; Lee S
Arch Pharm Res; 2018 Mar; 41(3):288-298. PubMed ID: 29196917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
